Changjiang Runfa Health Industry Co., Ltd. Stock price
Equities
002435
CNE100000QC7
Heavy Electrical Equipment
End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
4.68 CNY | -0.64% | -2.50% | +0.21% |
Sales 2022 | 3.47B 486M | Sales 2023 * | - | Capitalization | 5.77B 809M |
---|---|---|---|---|---|
Net income 2022 | 65M 9.11M | Net income 2023 * | - | EV / Sales 2022 | 1,47x |
Net cash position 2022 | 658M 92.17M | Net cash position 2023 * | - 0 | EV / Sales 2023 * | - |
P/E ratio 2022 | 88,6x | P/E ratio 2023 * | Employees | 2,405 | |
Yield 2022 | - | Yield 2023 * |
-
| Free-Float | 44.43% |
More Fundamentals
* Assessed data
More news
1 day | -0.64% | ||
1 week | -2.50% | ||
Current month | -0.43% | ||
1 month | +2.41% | ||
3 months | +6.36% | ||
6 months | +0.43% | ||
Current year | +0.21% |
1 week
4.63
4.80

1 month
4.49
4.86

Current year
4.21
5.90

1 year
4.21
6.25

3 years
3.85
9.89

5 years
3.41
9.89

10 years
2.92
9.89

Managers | Title | Age | Since |
---|---|---|---|
Yi Feng Lu
PSD | President | 49 | 2019 |
Bin Lu
BRD | Director/Board Member | 45 | 2007 |
Qiqin Qiu
BRD | Director/Board Member | 59 | 2007 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qiqin Qiu
BRD | Director/Board Member | 59 | 2007 |
Xia Qiu Yu
CHM | Chairman | 60 | 2007 |
Quan He Yu
BRD | Director/Board Member | 82 | 2007 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 64,346 M€ | +3.58% | ||
0.00% | 1,083 M€ | +3.56% | - | |
0.00% | 422 M€ | +3.68% | - | |
0.00% | 38 M€ | +0.49% | - | |
0.00% | 775 M€ | -2.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-03 | 4.68 | -0.64% | 9 508 500 |
23-12-01 | 4.71 | +0.21% | 9,535,200 |
23-11-30 | 4.7 | +0.64% | 9,761,650 |
23-11-29 | 4.67 | -1.89% | 14,526,730 |
23-11-28 | 4.76 | +0.42% | 16,048,560 |
End-of-day quote Shenzhen Stock Exchange, December 03, 2023
More quotes
ChangjiangRunfa Health Industry Co., Ltd., formerly ChangjiangRunfa Medicine Co., Ltd., is a China-based company mainly engaged in the production and sale of pharmaceutical raw materials and preparations. The Company is principally engaged in research and development, production and sales of pharmaceutical raw materials and preparations, proprietary Chinese medicines and providing medical services, medical investment and investment in health industry businesses. The Company is also engaged in the research, development, manufacture, sale and service of elevator guide rail system components. The Company's products include solid guide rails, rough guide rails, hollow guide rails, accessories and automotive sections, channel steel products, as well as escalator guide rails and others. The Company offers its elevator guide rail products for elevator manufacturers, including Mitsubishi, Otis, KONE and Thyssen. The Company distributes its products in domestic markets and to overseas markets.
Sector
Heavy Electrical Equipment
Calendar
2024-04-24
- Q4 2023 Earnings Release (Projected)
1st Jan change | Capi. | |
---|---|---|
+0.21% | 815 M $ | |
+10.66% | 35 503 M $ | |
+11.03% | 23 562 M $ | |
-16.09% | 23 039 M $ | |
+33.23% | 6 925 M $ | |
-1.06% | 2 311 M $ | |
+33.22% | 1 839 M $ | |
+14.15% | 1 820 M $ | |
+11.76% | 1 631 M $ | |
-.--% | 1 238 M $ |